We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+15.91%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$106M
AUM Growth
-$18.8M
(-15%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-24.76%
Top 10 Holdings %
Top 10 Hldgs %
63.48%
Holding
71
New
12
Increased
7
Reduced
8
Closed
22
Top Buys
| 1 |
Elevance Health
ELV
|
+$6.61M |
| 2 |
GSK
GSK
|
+$5.7M |
| 3 |
Eli Lilly
LLY
|
+$4.59M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$4.49M |
| 5 |
Boston Scientific
BSX
|
+$4.13M |
Top Sells
| 1 |
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
|
+$10.1M |
| 2 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$7.7M |
| 3 |
Biogen
BIIB
|
+$4.87M |
| 4 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$4.41M |
| 5 |
Globus Medical
GMED
|
+$4.38M |
Sector Composition
| 1 | Healthcare | 82.39% |
| 2 | Financials | 9.88% |
| 3 | Technology | 1.58% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$103B
| $11.6M | 10.89% |
260,658
+123,303
| +90% | +$5.7M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $10.5M | 9.88% |
58,089
+7,566
| +15% | +$1.3M |
|
|
3
Elevance Health
ELV
$92.7B
| $10M | 9.43% |
44,446
+31,028
| +231% | +$6.61M |
|
|
QTNT
4
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $7.06M | 6.65% |
35,653
-22,955
| -39% | -$4.41M |
|
5
Kura Oncology
KURA
$998M
| $6M | 5.65% |
392,027
+116,296
| +42% | +$1.71M |
|
6
Viking Therapeutics
VKTX
$4.41B
| $5.08M | 4.78% |
+1,250,250
| New | +$3.63M |
|
|
WCG
7
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.67M | 4.4% |
+23,200
| New | +$4.49M |
|
|
8
Eli Lilly
LLY
$1.03T
| $4.55M | 4.29% |
+53,900
| New | +$4.59M |
|
9
Emergent Biosolutions
EBS
$387M
| $4.25M | 4.01% |
91,533
+1,265
| +1% | +$53.2K |
|
|
10
Boston Scientific
BSX
$63.4B
| $3.71M | 3.5% |
+149,752
| New | +$4.13M |
|
11
Rigel Pharmaceuticals
RIGL
$762M
| $3.43M | 3.24% |
88,506
-67,825
| -43% | -$2.58M |
|
12
Pediatrix Medical
MD
$1.98B
| $3.02M | 2.85% |
+56,598
| New | +$2.67M |
|
13
Gyre Therapeutics
GYRE
$707M
| $2.76M | 2.6% |
26,971
-29,247
| -52% | -$1.49M |
|
|
AAAP
14
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.67M | 2.52% |
32,736
-19,846
| -38% | -$1.54M |
|
15
Icon
ICLR
$13B
| $2.65M | 2.49% |
23,604
| – | – |
|
16
Philips
PHG
$25.3B
| $2.56M | 2.42% |
89,359
| – | – |
|
17
UnitedHealth
UNH
$386B
| $2.52M | 2.38% |
11,430
| – | – |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.51M | 2.36% |
+19,000
| New | +$2.23M |
|
19
Xencor
XNCR
$1.11B
| $2.41M | 2.27% |
109,981
+76,881
| +232% | +$1.67M |
|
20
Vertex Pharmaceuticals
VRTX
$121B
| $2.23M | 2.1% |
14,874
| – | – |
|
|
LITS
21
Lite Strategy Inc
LITS
$33.9M
| $1.74M | 1.64% |
+41,346
| New | +$1.94M |
|
|
VCRA
22
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.68M | 1.58% |
55,454
-652
| -1% | -$18.6K |
|
|
ODT
23
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.25M | 1.18% |
+50,000
| New | +$1.18M |
|
24
Puma Biotechnology
PBYI
$421M
| $1.21M | 1.14% |
12,209
-15,012
| -55% | -$1.68M |
|
|
ADMS
25
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.19M | 1.12% |
+35,000
| New | +$977K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA